Indeed, FOXA1 has been hypothesized to be a mediator of hormonal response in breast and prostate cancer (Robinson and Carroll, 2012), and a hormonal regulatory complex involving FOXA1, GATA2 and AR has been shown to control gene expression in prostate cancer (Zhao et al., 2016). The gene discussed is FOXA1; the disease is prostate cancer.